AR and pulmonary arterial hypertension: Recent studies have shown a negative correlation between circulating testosterone, an endogenous androgen receptor ligand, and the severity of PAH in premenopausal female patients [59, 73], suggesting that VPS34 activation may potentially exhibit a sex hormone-dependent pattern in PAH.